Merrimack Pharmaceuticals (MACK)
(Delayed Data from NSDQ)
$15.04 USD
+0.04 (0.27%)
Updated May 7, 2024 04:00 PM ET
After-Market: $15.06 +0.02 (0.13%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Merrimack Pharmaceuticals, Inc. [MACK]
Reports for Purchase
Showing records 1 - 20 ( 64 total )
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for MACK 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Merrimack Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for MACK
Provider: ValuEngine, Inc